Therapy-related hematological malignancies after peptide receptor radionuclide therapy with (177)Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs (Q38642303)
Jump to navigation
Jump to search
scientific article published on 03 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapy-related hematological malignancies after peptide receptor radionuclide therapy with (177)Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs |
scientific article published on 03 August 2017 |
Statements
1 reference
Therapy-related hematological malignancies after peptide receptor radionuclide therapy with (177)Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs (English)
1 reference
Wouter de Herder
1 reference
Dik Kwekkeboom
1 reference
Eric Krenning
1 reference
Jaap Teunissen
1 reference
Boen Kam
1 reference
Hendrik Bergsma
1 reference
Kirsten van Lom
1 reference
Mark Konijnenberg
1 reference
3 August 2017
1 reference
1 reference
Identifiers
1 reference
1 reference